CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 6 No. 12
 

Panel Says to Keep Saccharin an ‘Anticipated’ Carcinogen

December 1, 1997

RESEARCH TRIANGLE PARK, North Carolina—Saccharin just missed winning a reprieve. By a 4-to-3 vote, an advisory panel recommended that the federal government continue to list the artificial sweetener as “reasonably anticipated to be a human carcinogen.”

The board of scientific counselors of the National Toxicology Program also recommended that the 9th edition of the federal “Report on Carcinogens” list ultraviolet light as a known human carcinogen, whether the source is sunlight or a tanning bed or booth.

Working under new rules that permit the listing of chemical mixtures as well as single chemicals, the board further urged that smokeless tobacco and inhaled tobacco smoke be added to the list of “known” human carcinogens. Certain chemicals present in tobacco and tobacco smoke already carry the “known” designation. The advisory group, however, sought to emphasize that tobacco products as a whole, whether smoked, chewed, or snorted, can cause cancer in humans.

Although the board recommended listing of the antiestrogen tamoxifen(Drug information on tamoxifen) (Nolvadex) as a known human carcinogen, it also strongly emphasized that the drug’s benefits in preventing breast cancer recurrence greatly outweigh its risks.

In its saccharin decision, the board rejected the advice of the scientific review committees of the National Institute of Environmental Health Sciences and the Interagency Committee Working Group for the Report on Carcinogens. Saccharin was labeled an “anticipated” carcinogen in 1981 on the basis of animals studies, including a 1977 Canadian rat study.

Among the other recommendations:

  • Add to the list of known human carcinogens benzidine dyes, used in textiles, paper, and leather, and strong inorganic acid mists containing sulfuric acid, used in making fertilizers, explosives, and plastics, and in petroleum refining.
  • Raise from “anticipated” to “known” carcinogen, cadmium, used in batteries; 1,3-butadiene, used in making synthetic rubber; and dioxin, an impurity formed in herbicide manufacture, incineration, and several industrial processes.
  • Add as “anticipated” carcinogens trichloroethylene, an industrial solvent once used to decaffeinate coffee; chloroprene, used in industrial rubber products and in adhesives in food packaging; and phenolphthalein, an ingredient once used in nonprescription laxatives.
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy